1. Are H sub(2)-antagonists safe enough for OTC use?

   Review 17 January 2013 Pages: 2 - 2

2. Stop prescribing flosequinan at 100 mg/day,

   News item 17 January 2013 Pages: 2 - 2

3. Be aware of drug-induced hypertension

   Review 17 January 2013 Pages: 3 - 3

4. Further development of deferiprone questioned on safety grounds

   News item 17 January 2013 Pages: 3 - 3

5. More adverse effects in pharmacy personnel handling antineoplastics

   Incidence study 17 January 2013 Pages: 3 - 3

6. Carvedilol's safety and efficacy confirmed

   Clinical study 17 January 2013 Pages: 4 - 4

7. Heparin anticoagulation is adversely affected by nitroglycerin

   Clinical study 17 January 2013 Pages: 4 - 4

8. Mechanisms for antidepressant-associated suicidal risk

   Review 17 January 2013 Pages: 4 - 4

9. Nephrotoxicity studies required

   Comment 17 January 2013 Pages: 4 - 4

10. Quinidine pharmacokinetics were not altered by either nifedipine or felodipine

    Volunteers 17 January 2013 Pages: 4 - 4

11. Tamoxifen – are the risks worth its benefits?

    Comment 17 January 2013 Pages: 4 - 4

12. Acetazolamide

    Case report 17 January 2013 Pages: 5 - 5

13. Adenosine

    Case report 17 January 2013 Pages: 5 - 5

14. Adenosine

    Case report 17 January 2013 Pages: 5 - 5

15. Amiodarone

    Case reports 17 January 2013 Pages: 5 - 5

16. Isradipine did not impair theophylline metabolism,

    Volunteers 17 January 2013 Pages: 5 - 5

17. Amlodipine

    Case reports 17 January 2013 Pages: 6 - 6

18. Anaesthetics

    Case reports 17 January 2013 Pages: 6 - 6

19. Anticonvulsants

    Case report 17 January 2013 Pages: 6 - 6

20. Aurothioglucose

    Case report 17 January 2013 Pages: 6 - 6

21. BCG vaccine

    Incidence study 17 January 2013 Pages: 6 - 6

22. Bezafibrate

    Case report 17 January 2013 Pages: 6 - 6

23. Bisoprolol

    Incidence study 17 January 2013 Pages: 6 - 6

24. Bupivacaine

    Case report 17 January 2013 Pages: 6 - 6

25. Campath-1H

    Case reports 17 January 2013 Pages: 7 - 7

26. Carbamazepine overdose

    Incidence study 17 January 2013 Pages: 7 - 7

27. Chlormezanone

    Case report 17 January 2013 Pages: 7 - 7

28. Ciprofloxacin interaction

    Volunteers 17 January 2013 Pages: 7 - 7

29. Clarithromycin

    Incidence study 17 January 2013 Pages: 7 - 7

30. Corticosteroids

    Incidence study 17 January 2013 Pages: 7 - 7

31. Cyclophosphamide

    Case report 17 January 2013 Pages: 8 - 8

32. Cyclosporin

    Clinical study 17 January 2013 Pages: 8 - 8

33. Danazol

    Incidence study 17 January 2013 Pages: 8 - 8

34. Deferoxamine overdose

    Case report 17 January 2013 Pages: 8 - 8

35. Desflurane

    Case report 17 January 2013 Pages: 8 - 8

36. Diethylstilbestrol

    Incidence study 17 January 2013 Pages: 8 - 8

37. Dobutamine

    Incidence study 17 January 2013 Pages: 8 - 8

38. Doxorubicin

    Case reports 17 January 2013 Pages: 8 - 8

39. Estrogen

    Incidence study 17 January 2013 Pages: 9 - 9

40. Fleroxacin

    Incidence study 17 January 2013 Pages: 9 - 9

41. Flosequinan

    Case report 17 January 2013 Pages: 9 - 9

42. Fluconazole interaction

    Case report 17 January 2013 Pages: 9 - 9

43. Fluoxetine

    Case reports 17 January 2013 Pages: 10 - 10

44. Gliclazide/glibenclamide

    Incidence study 17 January 2013 Pages: 10 - 10

45. Granulocyte-macrophage colony-stimulating factor

    Case report 17 January 2013 Pages: 10 - 10

46. Growth hormone human

    Case report 17 January 2013 Pages: 10 - 10

47. Halofantrine/mefloquine

    Case reports 17 January 2013 Pages: 10 - 10

48. Ibuprofen/aspirin/paracetamol

    Clinical study 17 January 2013 Pages: 10 - 10

49. Immunotherapy

    Case reports 17 January 2013 Pages: 11 - 11

50. Indomethacin

    Case report 17 January 2013 Pages: 11 - 11